Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody | Zendy

Alfredomaria Lurati | Zendy; Luca Bertani | Zendy; Katia Angela Re | Zendy; Mariagrazia Marrazza | Zendy; Daniela Bompane | Zendy; M. Scarpellini | Zendy

Open Access

Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody

Author(s) -

Alfredomaria Lurati,

Luca Bertani,

Katia Angela Re,

Mariagrazia Marrazza,

Daniela Bompane,

M. Scarpellini

Publication year - 2012

Publication title -

case reports in rheumatology

Language(s) - English

Resource type - Journals

eISSN - 2090-6889

pISSN - 2090-6897

DOI - 10.1155/2012/639612

Subject(s) - tocilizumab , giant cell arteritis , medicine , vasculitis , antibody , arteritis , immunology , interleukin 6 , pathology , inflammation , disease , rheumatoid arthritis

Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, affecting preferentially medium-large size arteries. Here we report a case of a female with a diagnosis of GCA based on temporal artery biopsy, successfully treated with tocilizumab, a humanized anti-interleukin-6 receptor antibody.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research